Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol NOL3 contributors: mct - updated : 29/10/2008
HGNC name nucleolar protein 3 (apoptosis repressor with CARD domain)
HGNC id 7869
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • an N terminal caspase recruitment domain (CARD)
  • a C terminal region rich in proline and glutamic acid
  • mono polymer polymer
    HOMOLOGY
    interspecies homolog to rattus Nol3 (85.4 pc)
    homolog to murine Nol3 (85.1 pc)
    Homologene
    FAMILY
    CATEGORY regulatory
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,cytosolic
    intracellular,nucleus,nucleoplasm
    intracellular,nucleus,nucleolus
    basic FUNCTION
  • involved in alternative splice site selection
  • inhibiting caspase 2 and 8
  • being a Ca(2+)-dependent regulator of caspase 8 and cell death
  • inhibitor of apoptosis in that it antagonizes both the extrinsic (death receptor) and intrinsic (mitochondrial/ER) apoptosis pathways
  • CELLULAR PROCESS cell life, antiapoptosis
    nucleotide, RNA splicing
    PHYSIOLOGICAL PROCESS
    text regulation of apoptosis
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA binding
    small molecule metal binding,
  • Ca2+
  • protein
  • alternating apoptosis induced by TRADD, FADD
  • binding to the RS domain of SFRS9 (Srp30c)
  • interacting with TFPT
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in the epithelium of primary breast cancers compared with benign breast tissue and to confer chemo- and radiation-resistance
    tumoral     --over  
    in most colon cancer cell lines and in almost all primary colon cancers compared with corresponding controls
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker marker of human colon cancer
    Therapy target
    ANIMAL & CELL MODELS